Also categorized in BoardMoves:
Target CEO Gregg Steinhafel Resigns In Data Breach Fallout
x hide permanently

Nektar Therapeutics Strengthens Board of Directors with Appointment of Biotechnology Veteran

biospace.com

SAN FRANCISCO, /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it has appointed Karin Eastham as an independent ...

Mentions: Nasdaq Karin Eastham Nektar Therapeutics